Sullivan, Jane M. Cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons: mechanisms of action. J. Neurophysiol. 82: 1286Neurophysiol. 82: -1294Neurophysiol. 82: , 1999. Cannabinoids, such as marijuana, are known to impair learning and memory perhaps through their actions in the hippocampus where cannabinoid receptors are expressed at high density. Although cannabinoid receptor activation decreases glutamatergic synaptic transmission in cultured hippocampal neurons, the mechanisms of this action are not known. Cannabinoid receptor activation also inhibits calcium channels that support neurotransmitter release in these cells, making modulation of these channels a candidate for cannabinoid-receptor-mediated effects on synaptic transmission. Whole cell patch-clamp recordings of glutamatergic neurons cultured from the CA1 and CA3 regions of the hippocampus were used to identify the mechanisms of the effects of cannabinoids on synaptic transmission. Cannabinoid receptor activation reduced excitatory postsynaptic current (EPSC) size by ϳ50% but had no effect on the amplitude of spontaneous miniature EPSCs (mEPSCs). This reduction in EPSC size was accompanied by an increase in paired-pulse facilitation measured in low (1 mM) extracellular calcium and by a decrease in paired-pulse depression measured in normal (2.5 mM) extracellular calcium. Together, these results strongly support the hypothesis that cannabinoid receptor activation decreases EPSC size by reducing release of neurotransmitter presynaptically while having no effect on postsynaptic sensitivity to glutamate. Further experiments were done to identify the molecular mechanisms underlying this cannabinoid-receptor-mediated decrease in neurotransmitter release. Cannabinoid receptor activation had no effect on the size of the presynaptic pool of readily releasable neurotransmitter-filled vesicles, eliminating reduction in pool size as a mechanism for cannabinoid-receptor-mediated effects. After blockade of Q-and N-type calcium channels with -agatoxin TK and -conotoxin GVIA; however, activation of cannabinoid receptors reduced EPSC size by only 14%. These results indicate that cannabinoid receptor activation reduces the probability that neurotransmitter will be released in response to an action potential via an inhibition of presynaptic Q-and N-type calcium channels. This molecular mechanism most likely contributes to the impairment of learning and memory produced by cannabinoids and may participate in the analgesic, antiemetic, and anticonvulsive effects of these drugs as well.
ter 1984; Howlett 1995) . In the hippocampus, where cannabinoid receptors are highly expressed (Herkenham et al. 1990 (Herkenham et al. , 1991 Matsuda 1990; Tsou et al. 1998) , cannabinoid receptor activation blocks long-term potentiation of field potentials (Collins et al. 1994 (Collins et al. , 1995 Devane et al. 1992; Nowicky et al. 1987; Stella et al. 1997; Terranova et al. 1995) . Recent experiments have shown that cannabinoid-receptor-mediated impairments of hippocampal long-term potentiation (LTP) and long-term depression (LTD) are due to a decrease in presynaptic neurotransmitter release (Misner and Sullivan 1999) . Because hippocampal LTP and LTD are believed to underlie certain forms of learning and memory, identifying the molecular mechanism mediating the decrease in neurotransmitter release produced by cannabinoid receptor activation may provide insights into the mechanism underlying the learning and memory impairments produced by marijuana. In the present paper, the effects of cannabinoid receptor activation on synaptic transmission of hippocampal neurons in culture were studied to elucidate the molecular mechanisms of cannabinoid action.
Cannabinoid receptor activation inhibits glutamatergic synaptic transmission in cultured hippocampal neurons through a presynaptic site of action (Shen and Thayer 1999; Shen et al. 1996) , but the molecular mechanisms mediating these effects are only partially understood. A clue to these mechanisms of action comes from the observation that cannabinoid receptor activation also inhibits N-as well as P-and/or Q-type calcium channels in cultured hippocampal neurons (Twitchell et al. 1997) and in other cellular systems (Mackie and Hille 1992; Mackie et al. 1995; Pan et al. 1996) . Because these calcium channels are known to support neurotransmitter release in hippocampal neurons (Reid et al. 1998; Reuter 1995; Scholz and Miller 1995; Takahashi and Momiyama 1993; Wheeler et al. 1994) , inhibition of these channels is a candidate mechanism by which cannabinoid receptor activation reduces glutamatergic transmission. In addition, cannabinoid receptor activation activates potassium channels (Deadwyler et al. 1993; Henry and Chavkin 1995; Mackie et al. 1995) , and modulation of these channels also may contribute to cannabinoid-receptormediated effects. Finally, cannabinoid receptor activation could decrease neurotransmitter release by reducing the size of the pool of readily releasable neurotransmitter-filled vesicles.
Using whole cell patch-clamping of cultured rat hippocampal neurons, I have found that cannabinoid-receptor-mediated inhibition of hippocampal excitatory postsynaptic currents (EPSCs) is due to a decrease in the probability that neurotransmitter will be released in response to an action potential, with no accompanying change in the postsynaptic sensitivity to glutamate. This decrease in the probability of release is mediated primarily via an inhibition of both Q-and N-type calcium channels.
M E T H O D S

Culture preparation
Rat hippocampal neurons isolated from the CA1-CA3 regions were cultured on microislands as described previously (Bekkers and Steven 1991; Furshpan et al. 1976 ). Neurons were plated onto a feeder layer of astrocytes that had been laid down 1-7 days earlier (see Levison and McCarthy 1991) and grown in high-glucose (20 mM) medium containing 10% horse serum. Neurons were grown without mitotic inhibitors and used for recordings only after a minimum of 21 days in culture because cannabinoid (CB1) receptors are not predominantly localized along neuronal processes until cells have been in culture for 3-4 wk (Twitchell et al. 1997) . To test for the involvement of inhibitory G proteins in CB1-receptor-mediated effects, some cultures were treated for 16 -24 h with 250 ng/ml pertussis toxin [Research Biochemicals International (RBI), Natwick, MA]; control sister cultures were treated with heat-inactivated (15 min, 100°C) pertussis toxin. All drug effects were tested on cells from at least two different cultures.
Electrophysiology
When a single neuron is grown on a small island of permissive substrate, it forms synapses on itself. Such connections are referred to as "autapses." All experiments were performed on isolated autaptic neurons.
Whole cell voltage-clamp recordings from autaptic neurons were carried out using an Axopatch 1B amplifier (Axon Instruments, Burlingame, CA). The extracellular solution contained (in mM) 119 NaCl, 5 KCl, 2.5 CaCl 2 (except where noted), 1.5 MgCl 2 , 30 glucose, 20 HEPES, and 0.1 mM picrotoxin (to block inhibitory GABAergic currents; RBI) plus 1 M glycine. Bovine serum albumin (1 mg/ml; Boehringer Mannheim, Indianapolis, IN, and Sigma, St. Louis, MO) was added to the extracellular solution to reduce nonspecific binding of WIN55,212-2, and toxins. A low concentration of tetrodotoxin (TTX; 2 nM; RBI) was included to prevent spontaneous firing of neurons and to ensure that the large EPSCs evoked in the older autaptic neurons used for these experiments did not trigger unwanted action potentials. For those experiments where the extracellular calcium concentration was altered, the magnesium concentration was adjusted to maintain a constant concentration of divalent cations. WIN55,212-2 (RBI), WIN55,212-3 (RBI), SR141716A (a generous gift from Dr. K. Mackie, University of Washington), -conotoxin GVIA (Alomone Labs, Jerusalem, Israel), and -agatoxin TK (Alomone Labs) were all applied for 0.5-3 min using a puffer pipette controlled by a picospritzer or, more rarely, by bath application. WIN55,212-2, WIN55,212-3, and SR141716A solutions were made up as 10 mM stock solutions in DMSO, stored at Ϫ20°C and used at a final DMSO concentration of Յ0.01%. For experiments using the puffer pipette, a vacuum pipette was used to clear the drug away rapidly. All cells served as their own control for the effects of WIN55,212-2 on EPSC size before and after SR141716A, -agatoxin TK, or -agatoxin TK plus -conotoxin GVIA application. Only cells that showed strong recovery (typically Ͼ80%) within 5-10 min of the termination of WIN55,212-2 application were used for data analysis.
Recording pipettes of 2-5 M⍀ were filled with (in mM) 121.5 K gluconate, 17.5 KCl, 9 NaCl, 1 MgCl 2 , 10 HEPES, 0.2 EGTA, 2 MgATP, and 0.5 LiGTP. Most experiments were done using perforated patches; for these experiments amphotericin B (solubilized, Sigma) was included in the pipette solution. Access resistance was monitored, and only cells with stable access resistance were included in the data analysis. The membrane potential was held at Ϫ60 mV, and EPSCs were evoked every 10 s by triggering an unclamped sodium spike with a 0.5-ms depolarizing step. Data were acquired at a rate of 2 kHz. The size of the recorded EPSCs was calculated by integrating the evoked current to yield a charge value. Calculating the charge value in this manner yields a direct measure of the amount of neurotransmitter released while minimizing the effects of cable distortion on currents generated far from the site of the recording electrode (the soma).
The amplitude and frequency of spontaneous mEPSCs were studied by recording continuously during 10 -60 s in the presence of TTX (2 nM). Data for mEPSC analysis were acquired at a rate of 5 kHz. The peak amplitudes of the mEPSCs were measured off-line semiautomatically using an adjustable amplitude threshold. All deflections from baseline that were greater than threshold were detected. Selected events then were examined visually, and any spurious events were rejected manually, whereas any missed events were flagged for inclusion in the mean amplitude and frequency calculations. mEPSC frequencies were calculated by dividing the total number of mEPSC events by the total time sampled.
Effects of WIN55,212-2 on paired-pulse responses were studied by interleaving trials in which a single depolarizing pulse was applied with trials in which two depolarizing pulses were applied at a 45-ms interval. The responses to single pulses were used to generate a template that could be subtracted from the response to the subsequent two-pulse trial to yield an accurate measurement of the response to the second of the pair of pulses. The peak amplitude of the response to the second pulse was averaged over three or more trials and divided by the averaged peak amplitude of the response to the first pulse to give a paired-pulse ratio (either PPF or PPD, depending on the relative sizes of the 2 averaged responses) before and after WIN55,212-2 application.
Hypertonic solution application
The size of the readily releasable pool of vesicles was measured electrophysiologically by application of hypertonic solution (normal extracellular solution plus 500 mM sucrose) to an isolated autaptic neuron using a puffer pipette controlled by a picospritzer. A vacuum pipette was used to clear the hypertonic solution rapidly. The hypertonic solution was applied over the entire island on which the autaptic neuron was located to ensure that the same population of synapses was activated every time the solution was applied. This solution evoked a large initial transient current that declined to a low steadystate level over ϳ3 s; hypertonic solution was applied for 4 -5 s to deplete the readily releasable pool fully. Data were acquired at a rate of 200 Hz. With the broad area of application of hypertonic solution and relatively slow data acquisition rate used for this study, individual mEPSCs were poorly resolved and were only seen superimposed on the larger current. The size of the readily releasable pool was calculated by integrating the current evoked by the hypertonic solution to yield a charge value. To estimate the readily releasable pool size more accurately, we corrected the integral of the current by subtracting away the amount of steady-state exocytosis that occurred during the hypertonic solution flow.
R E S U L T S
Cannabinoid receptor activation decreases the size of EPSCs in cultured hippocampal neurons
To study the effects of cannabinoid receptor activation on glutamatergic synaptic transmission, I applied the selective and potent cannabinoid receptor agonist WIN55,212-2 (Compton et al. 1992; D'Ambra et al. 1992 ) to autaptic hippocampal CA1 and CA3 neurons grown in culture for a minimum of 21 days, when cannabinoid receptors have become predominantly lo-calized to neurites (Twitchell et al. 1997 ). WIN55,212-2 (1 M) reduced EPSC size by 51.7 Ϯ 3.2% (mean Ϯ SE; P Ͻ 0.001, paired t-test; n ϭ 34; Fig. 1 ). Washout of the drug reversed these effects and allowed the EPSC to recover to 96.1 Ϯ 1.6% of its original size. Although every cell tested responded to WIN55,212-2, the degree of inhibition ranged from 19 to 89%, and there was both cell-to-cell and batch-tobatch variability in the response of neurons to the drug. This variability may explain the discrepancy between the degree of inhibition reported here and the more complete inhibition reported previously (Shen and Thayer 1999; Shen et al. 1996) .
Two lines of evidence indicate that WIN55,212-2 inhibition of EPSCs was mediated by CB1-type cannabinoid receptors (Matsuda et al. 1990) . First, the effect of WIN55,212-2 was effectively blocked by the selective CB1 inhibitor, SR141716A (Rinaldi-Carmona et al. 1994) : after application of 200 nM SR141716A, WIN55,212-2 produced only a 0.8 Ϯ 2.8% reduction of EPSC size (n ϭ 4; Fig. 1 ). Second, 1 M WIN55,212-3, an inactive form of WIN55,212-2 (Pacheco et al. 1991) , had no significant effect on EPSC size, producing a 2.3 Ϯ 3.5% reduction (n ϭ 6; Fig. 1 ). This latter control experiment was important because slightly higher (Ն 3 M) concentrations of active and inactive WIN55,212 can directly inhibit whole cell currents carried through Ca 2ϩ channels (Shen and Thayer 1998) . Thus at the 1 M concentration of WIN55,212-2 that was used for the experiments reported here, inhibition of EPSC size was mediated exclusively via CB1 cannabinoid receptor activation.
The effects of WIN55,212-2 were blocked by treating cultures overnight with pertussis toxin (n ϭ 5), whereas WIN55,212-2-mediated inhibition was unimpaired in cultures treated with heat-inactivated pertussis toxin (n ϭ 4; data not shown). These results strongly suggest that cannabinoid-receptor-mediated inhibition of EPSC size is mediated via a pertussis toxin-sensitive inhibitory G protein.
Effect of cannabinoid receptor activation is not due to a change in postsynaptic responsiveness to glutamate
The WIN55,212-2-mediated decrease in EPSC size could be due to changes in the amount of neurotransmitter released presynaptically and/or to changes in the postsynaptic responsiveness to glutamate. The amplitude of spontaneous mEPSCs was used to monitor changes in postsynaptic responsiveness to glutamate after cannabinoid receptor activation. Because spontaneous mEPSCs are the postsynaptic response to single spontaneously released synaptic vesicles, any change in postsynaptic responsiveness to glutamate should be reflected as a change in the amplitude of mEPSCs.
There was no effect of 1 M WIN55,212-2 on mEPSC amplitude measured in the presence of TTX, added to inhibit spontaneous action potential firing. Mean mEPSC amplitude was 25.6 Ϯ 0.4 pA before drug application and 25.8 Ϯ 0.5 pA after WIN55,212-2 application (n ϭ 6; Fig. 2A ). The lack of effect of WIN55,212-2 on mEPSC amplitude indicates that there was no WIN55,212-2-mediated change in the sensitivity of postsynaptic receptors to glutamate nor in the postsynaptic ionic driving force (Thompson et al. 1993) . These results are in agreement with a previous report that application of WIN55,212-2 had no significant effect on the response of cultured hippocampal neurons to exogenous application of the glutamate receptor agonist kainate (Shen et al. 1996) and with a recent report that application of WIN55,212-2 had no effect on the amplitude of mEPSCs recorded in cerebellar slices (Levenes et al. 1998) .
Interestingly, 1 M WIN55,212-2 did produce a small but significant (P Ͻ 0.05, paired t-test) decrease in the frequency of mEPSCs, from 8.5 Ϯ 2.0 mEPSCs per second before application of WIN55,212-2 to 6.8 Ϯ 1.6 per second after application of drug (n ϭ 6; Fig. 2B ). This decrease in mEPSC frequency also was observed after application of WIN55,212-2 to cerebellar slices (Levenes et al. 1998) and to hippocampal slices (Misner and Sullivan 1999) . All of these results, taken together, indicate that cannabinoid-receptor-mediated reduction in EPSC size is not due to a change in postsynaptic sensitivity to glutamate and therefore must be due to a change in the amount of neurotransmitter released presynaptically.
Effect of cannabinoid receptor activation is due to a decrease in the probability of neurotransmitter release
Measuring the relative amplitude of the synaptic response to two closely spaced action potentials provides a way to estimate the synaptic probability of release. The size of the response to the second action potential reflects a balance between two counteracting trends: the effect of residual calcium entering the presynaptic axon terminal during the first action potential and the effect of release triggered by the first action potential (Debanne et al. 1996; Mennerick and Zorumski 1995; Zucker 1989) . The elevation of intracellular calcium concentration will tend to enhance the probability of release, while the effect of release in response to the first action potential will diminish the FIG. 1. WIN55,212-2 reduces excitatory postsynaptic currents (EPSCs) in cultured hippocampal neurons by activation of CB1 cannabinoid receptors. Top: whole cell response from an autaptic hippocampal neuron evoked by a brief depolarizing pulse from Ϫ60 to Ϫ20 mV. A fast sodium spike (action potential) is followed by the EPSC. After application of 1 M WIN55,212-2, the EPSC was reduced by 51%. Washout of the drug restored the response to 105% of its original size. Scale bars: 2,000 pA, 25 ms. Bar graph shows average reduction in EPSC size (mean Ϯ SE) after application of 1 M WIN55,212-2 (51.7 Ϯ 3.2%; n ϭ 34), after washout of drug (3.9 Ϯ 1.6%), after application of 1 M inactive WIN55,212-3 (2.3 Ϯ 3.5%; n ϭ 6), or after application of 1 M WIN55,212-2 after exposure to the selective CB1 antagonist SR141716A (0.8 Ϯ 2.8%; n ϭ 4). These results indicate that 1 M WIN55,212-2 is acting at CB1 cannabinoid receptors and has no direct effects on presynaptic calcium channels at this concentration (Shen and Thayer 1998). probability of release (perhaps due to the depletion of synaptic vesicles). If the probability of release of transmitter is high when the first action potential arrives, then the depressing effect of release will tend to predominate and the second response will be smaller than the first; this phenomenon is known as paired-pulse depression (PPD). If, in contrast, the probability of release is low during the first stimulus, then the effects of elevated intracellular calcium will tend to predominate and the second response will be larger than the first; this phenomenon is known as paired-pulse facilitation (PPF).
Under normal recording conditions (2.5 mM Ca 2ϩ , 1.5 mM Mg 2ϩ ), the response to the second of a pair of action potentials evoked at a 45-ms interval was only 68 Ϯ 10% the size of the first response (n ϭ 6; Fig. 3 ). This magnitude of PPD indicates a rather high probability of release in response to the first stimulus. After application of 1 M WIN55,212-2 under these conditions, the size of EPSCs evoked by the first of the pair of stimuli was reduced by 55.5 Ϯ 7.5% of the predrug control, but the response to the second stimulus was now 101 Ϯ 10% of the size of the first response (P Ͻ 0.01, paired t-test). Thus application of WIN55,212-2 decreased PPD (increased the pairedpulse ratio), indicating that WIN55,212-2 decreased the probability of neurotransmitter release.
When the extracellular calcium concentration was lowered from 2.5 to 1 mM (3 mM Mg 2ϩ ), the response to the second stimulus of the pair increased to 117 Ϯ 12% the size of the first response (n ϭ 6; Fig. 3 ). This change from PPD to PPF on lowering extracellular calcium indicates that the probability of release in response to the first stimulus was reduced in the lower calcium solution (Creager et al. 1980; Debanne et al. 1996; Manabe et al. 1993; Mennerick and Zorumski 1995) , allowing the effect of residual calcium to predominate on the second stimulus. Under these lower calcium conditions, application of WIN55,212-2 reduced the size of EPSCs evoked by the first stimulus by 47.5 Ϯ 6.0% but enhanced the responses evoked by the second stimulus to 135 Ϯ 13% the size of the first (P Ͻ 0.01, FIG. 3. Cannabinoid receptor activation increases paired-pulse facilitation and decreases paired-pulse depression, indicating a reduction in the probability of neurotransmitter release. Top: autaptic response to a pair of pulses evoked at a 45-ms interval in low (1 mM) extracellular Ca 2ϩ before and after application of 1 M WIN55,212-2. Although the response to the first pulse was reduced by 55% after application of WIN55,212-2, the ratio of the 2nd response to the 1st rose from 1.08 before drug to 1.40 after drug application. Scale bars: 2,000 pA, 25 ms. Bar graph shows the average paired-pulse ratio (mean Ϯ SE) before drug, after application of 1 M WIN55,212-2 and after washout of drug in either low (1 mM) Ca 2ϩ (n ϭ 6) or normal (2.5 mM) Ca 2ϩ (n ϭ 6). See RESULTS for paired-pulse ratio values. Under both low-and high-calcium conditions, the paired-pulse ratio increased significantly (P Ͻ 0.01) after WIN55,212-2 application.
FIG. 2. Cannabinoid receptor activation does not change the postsynaptic sensitivity to glutamate but does reduce mEPSC frequency. A, top: spontaneous miniature EPSCs (mEPSCs) recorded from an autaptic hippocampal neuron in the presence of TTX before and after application of 1 M WIN55,212-2. Scale bars: 20 pA, 200 ms. Cumulative probability histogram of the mean mEPSC amplitude before (-; mean: 25.6 Ϯ 0.4 pA; n ϭ 6) and after (---; mean: 25.8 Ϯ 0.5 pA) application of 1 M WIN55,212-2. Curve after application of WIN55,212-2 overlies the curve before drug. Lack of change in mEPSC amplitude indicates that cannabinoid receptor activation has no effect on postsynaptic sensitivity to glutamate, the excitatory transmitter released by these neurons. Bar graph shows average mEPSC frequency (mean Ϯ SE) before drug application (8.5 Ϯ 2.0 Hz; n ϭ 6), after application of 1 M WIN55,212-2 (6.8 Ϯ 1.6 Hz), and after washout of the drug (11.2 Ϯ 2.4). Average mEPSC frequency decreased significantly (P Ͻ 0.05) after WIN55,212-2 application. paired t-test). Thus application of WIN55,212-2 in low Ca 2ϩ enhanced PPF, consistent with its increase of the paired-pulse ratio in 2.5 mM Ca 2ϩ . Taken together, these results indicate that activation of cannabinoid receptors decreases the probability of neurotransmitter release by a presynaptic action.
Effect of cannabinoid receptor activation is not due to a reduction in the size of the readily releasable pool of vesicles
One way that cannabinoid receptor activation could decrease the probability of release is by reducing the number of synaptic vesicles that are immediately available for release; this population of vesicles is called the readily releasable pool. The resting probability of release at a synapse is approximately linearly related to the size of this pool (Dobrunz and Stevens; Murthy et al. 1997) , so a decrease in pool size could account for the decrease in the probability of release observed after the application of WIN55,212-2.
To determine the effects of cannabinoid receptor activation on the size of this pool, pool size was estimated by applying hypertonic solution to these neurons and measuring the total charge transferred by synaptic currents (see METHODS). Application of hypertonic solution empties the readily releasable pool through a Ca 2ϩ -independent release mechanism (Rosenmund and Stevens 1996; Stevens and Tsujimoto 1995), so the size of the synaptic response to application of hypertonic solution reflects the number of vesicles in the pool. Provided there is no change in the postsynaptic sensitivity to glutamate, a change in the charge transferred by the synaptic response to hypertonic application indicates a change in the size of the readily releasable vesicle pool. Application of 1 M WIN55,212-2 had no effect on the size of the readily releasable pool, producing a 4.5 Ϯ 4.8% increase in pool size (n ϭ 6; Fig. 4 ). These results, considered in conjunction with the lack of effect of WIN55,212-2 on mEPSC amplitude, indicate that activation of cannabinoid receptors has no effect on the size of the readily releasable vesicle pool and that some other mechanism must underlie the WIN55,212-2-mediated decrease in the probability of neurotransmitter release.
Cannabinoid receptor activation decreases the probability of release by inhibiting presynaptic N-and Q-type calcium channels mediating neurotransmitter release
Because cannabinoid receptor activation inhibits N-and Pand/or Q-type channels in hippocampal neurons (Twitchell et al. 1997 ) and because these channels have been shown to support transmitter release in these cells (Reid et al. 1998; Reuter 1995; Scholz and Miller 1995; Takahashi and Momiyama 1993; Wheeler et al. 1994 ), inhibition of one or more of these subtypes of calcium channels is a good candidate mechanism for the WIN55,212-2-mediated reduction of EPSC size. I therefore examined the effects of WIN55,212-2 on EPSC size before and after selective blockade of each of these channel subtypes. A decrease in the effects of WIN55,212-2 after selective channel blockade would indicate that this channel subtype (or subtypes) plays a role in cannabinoid-receptormediated effects. (Randall and Tsien 1995) . Application of 25 nM -agatoxin TK reduced EPSC size by only 7.7 Ϯ 2.1% (n ϭ 6). The absence of an effect of -agatoxin TK at this concentration argues against P-type calcium channels contributing to release in cultured hippocampal neurons, in agreement with previous results (Reuter 1995; Scholz and Miller 1995; Wheeler et al. 1994) . These results indicate that inhibition of P-type channels cannot be a mechanism for the WIN55,2122 -mediated reduction of EPSCs.
EFFECT OF Q-TYPE CALCIUM CHANNEL BLOCKADE ON WIN55,212-2-MEDIATED REDUCTION OF EPSCS. To test the possible contribution of Q-type calcium channel inhibition to WIN55,212-2-mediated reduction of EPSCs, the concentration of -agatoxin TK was increased to 0.5-1 M. At concentrations Ͼ100 nM, -agatoxin TK selectively blocks not only P-type but also Q-type Ca 2ϩ channels (Mintz et al. 1992; Wheeler et al. 1994) . Application of 0.5-1 M -agatoxin TK reduced EPSC size by 57.8 Ϯ 5.7% (n ϭ 6), an effect comparable with that reported for hippocampal neurons maintained in culture for Ն 21 days (Scholz and Miller 1995) . Given that the lower concentration of this toxin had little effect on EPSC size, the reduction in EPSC size seen after application of the higher concentration of toxin must be due to blockade of Q-type channels. After application of 0.5-1 M -agatoxin TK, application of 1 M WIN55,212-2-blocked EPSC size by FIG. 4. Cannabinoid receptor activation does not decrease the probability of transmitter release by reducing the size of the readily releasable vesicle pool. Top: whole cell responses from an autaptic hippocampal neuron evoked by a 5-s application of hypertonic solution. After an initial peak in release, the response declines to a low steady-state level. This steady-state response is believed to reflect release of vesicles that are being drawn from the reserve pool of vesicles several microns away from the active zone and was subtracted from the current integral calculations used to estimate the size of the readily releasable pool. Although 1 M WIN55,212-2 application reduced this neuron's EPSC by 60%, the size of the readily releasable pool was actually slightly larger (by 10%) after drug application. Scale bars: 500 pA, 1 s. Bar graph shows the size of the readily releasable vesicle pool normalized to the predrug control (mean Ϯ SE) after application of 1 M WIN55,212-2 (1.05 Ϯ 0.05; n ϭ 6) or after washout of the drug (1.01 Ϯ 0.06). Lack of change in the size of the readily releasable pool after WIN55,212-2 application means that a reduction in pool size cannot account for the cannabinoid-receptor-mediated decrease in EPSC size.
64.8 Ϯ 7.0% (n ϭ 6; Fig. 5 ). The WIN55,212-2-mediated reduction in EPSC size that persists after blockade of Q-type calcium channels indicates either that WIN55,212-2 does not mediate its effects through these channels, or that WIN55,212-2 mediates its effects through the combined inhibition of Q-type channels and another subtype of calcium channel that also supports release in these neurons.
EFFECT OF N-TYPE CALCIUM CHANNEL BLOCKADE ON WIN55,212-2-MEDIATED REDUCTION OF EPSCS. To test the possible contribution of N-type calcium channel inhibition to WIN55,212-2-mediated reduction of EPSCs, I investigated the effects of 1 M -conotoxin GVIA. -Conotoxin GVIA selectively blocks N-type Ca 2ϩ channels (Kasai et al. 1987; Williams et al. 1992) . Application of 1 M -conotoxin GVIA reduced EPSC size by 39.8 Ϯ 2.7% (n ϭ 6), comparable with results reported previously for cultured hippocampal neurons (Reid et al. 1998; Scholz and Miller 1995) . After application of 1 M -conotoxin GVIA, application of 1 M WIN55,212-2 blocked EPSC size by 62.2 Ϯ 3.0% (n ϭ 6; Fig. 5 ). The WIN55,212-2-mediated reduction in EPSC size that persists after blockade of N-type calcium channels indicates either that WIN55,212-2 does not mediate its effects through these channels or that WIN55,212-2 mediates its effects through the combined inhibition of N-type channels and another subtype of calcium channel that also supports release in these neurons.
EFFECT OF COMBINED Q-AND N-TYPE CALCIUM CHANNEL
BLOCKADE ON WIN55,212-2-MEDIATED REDUCTION OF EPSCS. To test the possibility that WIN55,212-2 mediates its effects through the combined inhibition of Q-and N-type calcium channels, the effects of WIN55,212-2 were tested before and after the combined application of -agatoxin TK and -conotoxin GVIA. Combined application of 0.5-1 M -agatoxin TK and 1 M -conotoxin GVIA reduced EPSC size by 87.2 Ϯ 3.4% (n ϭ 12), an effect comparable with that reported for hippocampal neurons maintained in culture for Ն21 days (Scholz and Miller 1995) . After application of 0.5-1 M -agatoxin TK and 1 M -conotoxin GVIA, application of 1 M WIN55,212-2 reduced EPSC size by only 13.8 Ϯ 8.5% (n ϭ 12; P Ͻ 0.001, paired t-test; Fig. 5 ). In 7 of 12 neurons, all of which responded to WIN55,212-2 before coapplication of -agatoxin TK and -conotoxin GVIA, WIN55,212-2 had no inhibitory effect at all after the coapplication of these toxins. Linear regression analysis (least-squares method) revealed no significant correlation between the reduction of EPSC size by coapplication of -agatoxin TK and -conotoxin GVIA and the reduction of EPSC size by WIN55,212-2 after toxin application (regression slope ϭ Ϫ0.11 Ϯ 0.12; r 2 ϭ 0.08, not significantly different from 0). Taken together, these results indicate that the WIN55,212-2-mediated reduction of EPSCs is mediated primarily by inhibiting both Q-and N-type calcium channels supporting glutamate release in hippocampal neurons.
EFFECT OF LOW EXTRACELLULAR CALCIUM ON WIN55,212-2-MEDIATED REDUCTION OF EPSCS. WIN55,212-2's effects on EPSC size were tested in low extracellular calcium to rule out the possibility that inhibition of these effects by combined application of -agatoxin TK and -conotoxin GVIA is due either to inaccurate measurement of small EPSCs or to a minimal requirement for calcium in the presynaptic terminal. EPSCs first were recorded in normal (2.5 mM) extracellular calcium. The extracellular Ca ). This decrease in extracellular Ca 2ϩ reduced EPSC size by 89.0 Ϯ 3.4% (n ϭ 4), comparable with the reduction after coapplication of -agatoxin TK and -conotoxin GVIA. Under these low-Ca 2ϩ conditions, application of 1 M WIN55,212-2 further reduced the EPSC size by 76.0 Ϯ 7.1% in these same cells (data not shown). Simply reducing intracellular calcium therefore does not inhibit WIN55,212-2's effects on EPSC size. These results indicate that the inhibition of WIN55,212-2's effects on EPSC size after toxin blockade of Q-and N-type calcium channels was due to the selective occlusion of the molecular targets of cannabinoid receptor activation.
D I S C U S S I O N
Activation of cannabinoid receptors by WIN55,212-2 decreased the size of EPSCs by ϳ50%. This effect was entirely presynaptic: there was no change in the amplitude of spontaneous mEPSCs, indicating that there was no change in postsynaptic responsiveness to glutamate. The cannabinoid-receptormediated decrease in EPSC size was accompanied by an FIG. 5. Blockade of Q-and N-type calcium channels significantly reduces cannabinoid receptor-mediated EPSC inhibition. Top: whole cell responses from hippocampal neurons showing the effect of 1 M WIN55,212-2 before and after the combined application of 1 M -agatoxin TK and 1 M -conotoxin GVIA, blockers of Q-and N-type calcium channels, respectively. Before toxin application, WIN55,212-2 reduced the EPSC of this neuron by 51%. After toxin application, the EPSC was reduced by 92%, but application of WIN55,212-2 had no further effect on EPSC size. The apparent change in the sodium spike amplitude after toxin application is an artifact of the change to higher gain that was used to record the smaller posttoxin response accurately. Scale bars: 1,000 pA, 25 ms. Bar graph shows the average reduction in EPSC size produced by 1 M WIN55,212-2 after application of 0.5-1 M -agatoxin TK (AGA) alone (64.8 Ϯ 7.0%; n ϭ 6), after application of 1 M -conotoxin GVIA (CTX) alone (62.2 Ϯ 3.0%; n ϭ 6), after combined application of 0.5-1 M -agatoxin TK and 1 M -conotoxin GVIA (13.8 Ϯ 8.5%; n ϭ 12), and under control conditions for the neurons used for the combined application studies (49.9 Ϯ 6.0%). The combined application of -agatoxin TK and -conotoxin GVIA significantly (P Ͻ 0.001) reduced the effects of WIN55,212-2 on EPSC size, indicating that WIN55,212-2 acts by inhibiting Q-and N-type calcium channels to decrease release probability in hippocampal neurons. increase in PPF (or by a decrease in PPD), indicating that the decrease in EPSC size was due to a decrease in the probability that neurotransmitter would be released in response to an action potential. This decrease in the probability of release was not due to a change in size of the pool of readily releasable vesicles but was instead the result of cannabinoid-receptormediated inhibition of presynaptic Q-and N-type calcium currents supporting glutamate release in hippocampal neurons.
Cannabinoid receptor activation recently has been found to inhibit N-and P-and/or Q-type calcium currents measured at the somas of cultured rat hippocampal neurons (Shen and Thayer 1998; Twitchell et al. 1997) . These studies did not, however, establish that this inhibition was responsible for the cannabinoid-receptor-mediated change in neurotransmitter release. The finding that WIN55,212-2-mediated inhibition dropped from 50 down to 14% after exposure to Q-and N-type calcium channel blockers is evidence that inhibition of these channels is the primary mechanism of cannabinoid-receptormediated reduction in the probability of transmitter release. If there were other major mechanisms underlying cannabinoidreceptor-mediated inhibition of synaptic transmission that were downstream of calcium entry, one would not expect to find a lack of effect of WIN55,212-2 on the majority of cells tested after blockade of Q-and N-type calcium channels. The formal possibility remains that cannabinoid receptor activation modulates a protein that mediates release and is associated selectively with Q-and N-type calcium channels. However, the degree of inhibition of synaptic currents is very close to what would be expected given the degree of cannabinoid-receptormediated inhibition of Q-and N-type calcium currents reported previously (Shen and Thayer 1998; Twitchell et al. 1997 ). This correlation argues strongly for Q-and N-type calcium channel inhibition as the primary mechanism for the observed effects on EPSC size. In addition, the ability of WIN55,212-2 to inhibit EPSC size normally in low extracellular calcium, as well as the lack of correlation between the inhibition of EPSC size by combined application of -agatoxin TK and -conotoxin GVIA and the inhibition of EPSC size by WIN55,212-2 after toxin blockade, argues against the possibility that cannabinoid-receptor-mediated inhibition is dependent on a critical concentration of calcium in the presynaptic terminal. The complex pattern of effects of WIN55,212-2 on EPSC size after the separate and combined application of Q-and N-type calcium channel blockers is likely due to the complicated consequences of inhibiting channels that share the responsibility of supporting release by controlling the entry of a second messenger (Ca 2ϩ ) that exerts its effect on release with a fourth-order cooperativity (see Scholz and Miller 1996; Wheeler et al. 1996 ; Wu and Saggau 1994 for related discussion). As low concentrations of -agatoxin TK had little effect on EPSC size and therefore no obvious effect on neurotransmitter release, inhibition of P-type calcium channels does not contribute significantly to the effects of WIN55,212-2.
Although the combined application of -agatoxin TK and -conotoxin GVIA completely blocked the effects of WIN55,212-2 in 7 of 12 neurons, some reduction in EPSC size was still observed in 5 of 12 cells. What might explain this persistent effect? First, the residual reduction could be due to incomplete blockade of Q-and N-type channels. A second possibility is that after blockade of N-, P-, and Q-type calcium channels, there are still two or more subtypes of calcium channel that support the small amount of transmitter release that remains. If only some of those subtypes of channel are susceptible to cannabinoid-receptor-mediated inhibition, then the persistence of WIN55,212-2 effects could be explained by a cell-to-cell variability in the proportion of cannabinoid-receptor-sensitive calcium channels supporting release after Qand N-type channel blockade. A third possibility is that the residual effects of WIN55,212-2 after -agatoxin TK and -conotoxin GVIA application were due to cannabinoid-receptor-mediated activation of potassium channels (Deadwyler et al. 1993; Henry and Chavkin 1995; Mackie et al. 1995) .
Cannabinoid receptor activation previously has been found to activate inwardly rectifying potassium channels (Henry and Chavkin 1995; Mackie et al. 1995) and transient A-type potassium channels in cultured hippocampal neurons (Deadwyler et al. 1993) . Activation of potassium channels could reduce EPSC size in three different ways: by shortening the duration of the action potential and decreasing calcium entry into the presynaptic terminal; by shunting postsynaptic currents; and by influencing excitability. However, the lack of effect of cannabinoid receptor activation on action potential duration and amplitude in cultured hippocampal neurons (Shen et al. 1996) suggests that changes in A-type potassium currents do not play a role in WIN55,212-2-mediated effects in these cells. A cannabinoid-receptor-mediated increase in the inwardly rectifying potassium channel (Henry and Chavkin 1995; Mackie et al. 1995) could reduce the size of EPSCs by shunting synaptic current, but the absence of a change in mEPSC amplitude (shown here; Levenes et al. 1998) , as well as the lack of effect of WIN55,212-2 on resting membrane potential or action potential threshold (Shen et al. 1996) , argues against this possibility. Cannabinoid-mediated changes in spike firing patterns may contribute to marijuana's effects in vivo but would not be expected to contribute to the effects observed here in cells under voltage-clamp control. Assessing the contribution of these potential changes in excitability will require further experiments beyond the scope of this study. Finally, it remains possible that cannabinoids modulate potassium channels that are expressed in vivo, but not in the cultured cells used for the experiments described here. In summary, cannabinoid-receptor-mediated reduction of EPSCs is due primarily to inhibition of N-and Q-type calcium channels; inhibition of other calcium channels and perhaps activation of potassium channels also may play a role in these effects, albeit a less significant one.
The observation that WIN55,212-2 reduced the frequency of mEPSCs suggests that cannabinoid receptor activation has effects in addition to its inhibition of calcium channels. A decrease in mEPSC frequency previously has been observed in response to several other agonists of presynaptic receptors that inhibit synaptic transmission, such as adenosine and baclofen (Scanziani et al. 1992; Thompson et al. 1993 ). Because concentrations of calcium channel blockers sufficient to abolish all evoked transmitter release have no effect on mEPSC frequency, changes in mEPSC frequency are not likely to be the result of changes in Ca 2ϩ influx at resting membrane potentials (Scanziani et al. 1992) . The cannabinoid-receptor-mediated decrease in mEPSC frequency therefore may reflect a direct effect on proteins involved in vesicular release. These effects may contribute to the residual inhibition of release after combined application of -agatoxin TK and -conotoxin GVIA.
What is the mechanism of this cannabinoid-receptor-medi-ated inhibition of calcium channels? Almost certainly it occurs via activation of a pertussis-toxin-sensitive inhibitory G protein (Howlett 1995) . Pertussis toxin treatment blocked the effects of cannabinoid receptor activation on inhibition of calcium channels (Mackie and Hille 1992; Mackie et al. 1995; Pan et al. 1996; Twitchell et al. 1997 ) and activation of potassium channels (Deadwyler et al. 1993; Mackie et al. 1995) . Pertussis toxin treatment previously was found to block WIN55,212-2-mediated inhibition of synaptic transmission in cultured hippocampal neurons (Shen et al. 1996) , a result confirmed here by the finding that pertussis toxin treatment blocked the effects of cannabinoid receptor activation on EPSC size. Taken together, these data provide strong evidence supporting activation of an inhibitory G protein as the mechanism for cannabinoid-receptor-mediated calcium channel inhibition and consequent reduction in the probability of neurotransmitter release. Inhibition of neurotransmitter release is likely to play a role in the learning and memory deficits produced by marijuana and also may underlie some of the potential therapeutic benefits of marijuana.
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